24/7 Emergency & General Advisory
π¨ 24/7 Medical Emergency
Non-Emergency Advisory
10:00 AM β 6:00 PM, MonβSat
For appointments & general queries.
Join our healthcare community
Stay updated with our latest healthcare news and your appointments.
Learn about the safety of Aimovig (erenumab) during pregnancy and breastfeeding, including risks, benefits, and when to consult a doctor.

Migraine headaches can be debilitating, significantly impacting a person's quality of life. For many, Aimovig (erenumab-aooe) has been a breakthrough medication, offering a new way to prevent migraine episodes. However, when it comes to pregnancy and breastfeeding, questions naturally arise about the safety and implications of using such medications. This article aims to provide clear, practical information for Indian readers regarding Aimovig's use during these sensitive periods.
Aimovig is a prescription medication used to prevent migraine headaches. It belongs to a class of drugs called CGRP inhibitors, which work by blocking the activity of a molecule called calcitonin gene-related peptide (CGRP), a substance known to play a role in migraine pain.
The safety of Aimovig during pregnancy is a crucial concern for women of childbearing age who experience migraines. Currently, it is not known whether Aimovig is safe to use during pregnancy. While animal studies have not shown negative effects in pregnant animals treated with Aimovig, it's important to remember that animal studies do not always accurately predict human responses.
Because of this uncertainty, Aimovig is generally not prescribed to individuals who are pregnant or planning to become pregnant. Your doctor will carefully weigh the potential risks and benefits before making any treatment decisions.
Migraine itself can pose risks during pregnancy. Published data suggests that individuals with a history of migraine may have an increased risk of developing conditions like preeclampsia and high blood pressure during pregnancy. Therefore, the decision to use Aimovig or not during pregnancy involves a complex discussion between you and your doctor. They will consider:
If you are using Aimovig and become pregnant, or if you are pregnant and considering using Aimovig, it is highly recommended to enroll in the drug's pregnancy registry. A pregnancy registry is a vital tool for gathering information on how medications affect pregnant individuals and their babies. This data helps healthcare professionals understand the real-world impact of these drugs.
To learn more about the Aimovig pregnancy registry, you can:
Similar to pregnancy, the safety of Aimovig use while breastfeeding is also not well-established. It is not known whether Aimovig passes into breast milk or if it could affect a nursing infant. Therefore, if you are breastfeeding or planning to breastfeed, it is essential to have a thorough discussion with your doctor.
Your doctor will help you evaluate the potential benefits of using Aimovig for your migraine control against the unknown risks to your baby. They may suggest alternative treatments or strategies that are considered safer for breastfeeding mothers and infants.
It is crucial to consult your doctor in the following situations:
For pregnant individuals experiencing migraines, doctors often recommend a multi-faceted approach that prioritizes safety. This may include:
Aimovig has been a valuable tool for many in managing migraines. However, its use during pregnancy and breastfeeding requires careful consideration due to the lack of definitive safety data. Open and honest communication with your healthcare provider is paramount. They can guide you through the risks and benefits, discuss alternative management strategies, and help you make the best decision for your health and the health of your baby. Remember, your doctor's advice is tailored to your specific health needs and circumstances.
Visit Hospital
Near You

Can a simple blood draw really predict dementia decades before memory problems start? In 2026, several major studies said yes β one found a protein called p-tau217 predicted risk up to 25 years ahead in women, while another found a 78% risk of cognitive impairment within 10 years in people with the
July 23, 2026

Learn about Parkinson's disease symptoms, causes, stages, and treatment options. A complete guide for patients and caregivers in simple language.
June 13, 2026
Seeking a brain specialist in Kamarhati? Doctar connects you with leading neurologists and neurosurgeons for expert care. Book appointments now.
May 20, 2026